4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital AmaurosisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Leber congenital amaurosis, Meckel syndrome, type 4, congenital stationary night blindness autosomal dominant 1, enhanced S-cone syndrome, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosaActive, not recruitingPhase 1 / Phase 22026-07-31NCT05203939
Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis PigmentosaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, congenital stationary night blindness autosomal dominant 1, congenital stationary night blindness autosomal dominant 2, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosaActive, not recruitingNot stated2026-05-06NCT06323772
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucomacongenital stationary night blindness autosomal dominant 1, eye disorder, glaucoma, ocular hypertension, open-angle glaucomaRecruitingPhase 1 / Phase 22026-05-04NCT06921317
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, congenital stationary night blindness autosomal dominant 1, contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, eye disorder, hereditary disease, inherited retinal dystrophy, nervous system disorder, retinal degeneration, retinal disorder, retinitis, retinitis pigmentosa, vision disorderActive, not recruitingPhase 1 / Phase 22022-05-06NCT04123626